- Research works
- 21 ▼ 66% vs 2013–17
- Citations
- 321 15.1 per fractional work
- Top-10% rate
- 15.9% record average 16.5%
- Open access
- 54% world 28%
Not ranked overall: Biotherapy Institute of Japan is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Biotherapy Institute of Japan?
By fractional works in all years, weighted toward what it does more of than the world: Natural Killer Cells, NK Cell Recognition, Cancer Immunotherapy, Lymphoma, Immunotherapy, Tumor Regression, CAR T Cells and Chimeric Antigen Receptor.
- Mesenchymal Stem Cells
- Vaccine
- Dendritic Cells
- TGF-ß
- Chimeric Antigen Receptor
- Tumor Regression
- Lymphoma
- Natural Killer Cells
- NK Cell Recognition
- Cancer Immunotherapy
- Immunotherapy
- CAR T Cells
- Foxp3
- Innate Immunity
- Immunity
- Immune Response
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 16 words, with their numbers
- NK Cell Recognition6▲ 260×1 topic
- Natural Killer Cells6▲ 260×1 topic
- Cancer Immunotherapy4▲ 126×2 topics
- Lymphoma3▲ 98×2 topics
- Immunotherapy3▲ 22×2 topics
- Tumor Regression3▲ 160×2 topics
- CAR T Cells3▲ 286×1 topic
- Chimeric Antigen Receptor3▲ 286×1 topic
- Foxp32▲ 96×1 topic
- TGF-ß2▲ 42×1 topic
- Innate Immunity1▲ 17×3 topics
- Dendritic Cells1▲ 46×1 topic
- Immunity1▲ 16×1 topic
- Vaccine1▲ 13×3 topics
- Immune Response1▲ 7.9×3 topics
- Mesenchymal Stem Cells1▲ 40×2 topics
Which research topics does Biotherapy Institute of Japan publish most on?
By volume in 2022–2025: Immune Cell Function and Interaction, COVID-19 Clinical Research Studies, Tissue Engineering and Regenerative Medicine and Mesenchymal stem cell research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immune Cell Function and Interaction Immunology 1 works
- 2 COVID-19 Clinical Research Studies Infectious Diseases 0 works
- 3 Tissue Engineering and Regenerative Medicine Surgery 0 works
- 4 Mesenchymal stem cell research Genetics 0 works
- 5 COVID-19 and Mental Health Clinical Psychology 0 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 7 CAR-T cell therapy research Oncology 0 works
- 8 Electrospun Nanofibers in Biomedical Applications Biomaterials 0 works
- 9 T-cell and B-cell Immunology Immunology 0 works
- 10 Autoimmune and Inflammatory Disorders Research Hematology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Biotherapy Institute of Japan's research output changed?
Output in 2018–2022 was 66% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.